Subject(s)

COVID-19 , Delivery of Health Care , Nurse Specialists , Primary Health Care , Self Care , Urinary Incontinence/nursing , Urinary Tract Infections/nursing , Administration, Topical , Adrenergic beta-Agonists/therapeutic use , Anti-Bacterial Agents/therapeutic use , Cholinergic Antagonists/therapeutic use , Estrogens/therapeutic use , Health Services Accessibility , Humans , Incontinence Pads , Life Style , Pelvic Floor , Recurrence , SARS-CoV-2 , Self-Management , State Medicine , United Kingdom , Urinary Bladder, Overactive/drug therapy , Urinary Bladder, Overactive/nursing , Urinary Incontinence, Stress/nursing , Urinary Tract Infections/drug therapy